UnitedHealth Group Incorporated
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
US
US
US
US
US
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track UnitedHealth Group Incorporated in real time with a live news feed covering UnitedHealth Group Incorporated stock news, official press releases, company announcements, and an archive of historical UnitedHealth Group Incorporated news. ...more
Loading news...
Loading more...
2:16 PM | Friday | Nov 13, 2026
Sign in to download news snippet
UnitedHealth Group Incorporated's UNH Optum Rx delivered higher operating earnings despite declining prescription volumes in the third quarter of 2026. Stronger profitability, supported by biosimilar adoption and operational efficiencies, highlights the segment's resilience amid membership-related pressures.
Read full articleNo data available for this time period.
Change the time range to see results.
UnitedHealth Group Incorporated's UNH Optum Rx delivered higher operating earnings despite declining prescription volumes in the third quarter of 2026. Stronger profitability, supported by biosimilar adoption and operational efficiencies, highlights the segment's resilience amid membership-related pressures.
Read full article
UnitedHealth once looked like the safest name in health care, and its dividend keeps climbing anyway. So why has a five-year holder gone nowhere while the index raced ahead, and what would have to change for the stock to catch up?
Read full article
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock?
Read full article
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Read full article
Market volatility is unpleasant, but it's important that investors don't force themselves into a false choice between safety and growth. Over the last two years, technology stocks, particularly AI stocks, have driven strong portfolio gains for active and passive investors.
Read full article
Management has done a solid job correcting the miscalculations of 2025.
Read full article
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock?
Read full article
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Read full article
Market volatility is unpleasant, but it's important that investors don't force themselves into a false choice between safety and growth. Over the last two years, technology stocks, particularly AI stocks, have driven strong portfolio gains for active and passive investors.
Read full article
Management has done a solid job correcting the miscalculations of 2025.
Read full article
UnitedHealth raised its outlook for 2026 adjusted earnings per share from at least $17.75 in January to at least $20.50 in October. Optum Health, part of the company, had $735 million in operating earnings in the third quarter, up from $41 million a year earlier.
Read full article
UnitedHealth's profits are rising despite fewer members and lower Optum Health sales, as higher margins and pricing discipline fuel a recovery amid medical-cost risks.
Read full article
Ashton Thomas Private Wealth LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 5.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,111 shares of the healthcare conglomerate's stock after selling 1,348 shares
Read full article
Alps Advisors Inc. trimmed its stake in UnitedHealth Group Incorporated (NYSE: UNH) by 14.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 23,866 shares of the healthcare conglomerate's stock after selling 3,892 shares during the quarter. Alps Advisors Inc.
's holdings
Three words sum up this historically successful investing strategy.
Read full article
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read full article
No data available for this time period.
Change the time range to see results.